Expression of soluble Fas and soluble FasL in human nucleus pulposus cells

• Published in: International journal of clinical and experimental pathology Vol. 6; no. 8; pp. 1567 - 1573
• Main Authors: Sun, Zhen, Wan, Zhong-Yuan, Liu, Zhi-Heng, Guo, Yun-Shan, Yin, Jun-Bin, Duan, Chun-Guang, Gao, Yang, Li, Tao, Wang, Hai-Qiang, Luo, Zhuo-Jing
• Format: Journal Article
• Language: English
• Published: United States e-Century Publishing Corporation 01.01.2013
• Subjects: Adult; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Fas Ligand Protein - analysis; Fas Ligand Protein - biosynthesis; fas Receptor - analysis; fas Receptor - biosynthesis; Female; Humans; Intervertebral Disc - metabolism; Intervertebral Disc - pathology; Intervertebral Disc Degeneration - metabolism; Intervertebral Disc Degeneration - pathology; Male; Original; Real-Time Polymerase Chain Reaction; Young Adult; soluble FasL; immune privilege; Intervertebral disc; nucleus pulposus; soluble Fas
• ISSN: 1936-2625

The study aimed for addressing the expression of soluble Fas (sFas) and soluble Fas Ligand (sFasL) in human nucleus pulposus (NP) and its attendant relationship with disc degeneration. Human NP samples were collected from patients with disc degeneration and cadavers as degenerate and normal groups, respectively. Subsequently, NP cells were cultured in monolayer. ELISA was performed to identify the expression levels of sFas and sFasL in the supernatant of NP cell cultures in vitro. Quantitative real-time PCR was used to detect the expression of sFas and sFasL in human NP cells in mRNA solution. The study comprised 12 degenerate and 8 normal cadaveric NP samples. The concentration value of sFas in the supernatant was significantly higher from degenerate NP than that from normal NP at each time point. In contrast, sFasL was significantly lower at each time point. Moreover, the expression of sFas and sFasL reached the peak at various early stages of cell cultures and decreased thereafter. Furthermore, the mRNA level of Fas in degenerate NP cells was significantly higher than that in normal cells; whereas FasL showed an opposite pattern. The study is the first addressing the expression of sFas and sFasL in human NP cell cultures. Moreover, the expression of sFas and sFasL varies with culture time in vitro with different levels in degenerate and normal settings. These findings indicate that sFas and sFasL might play a role in intervertebral disc degeneration.